sesamin has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, L; Li, S; Liu, Q; Qiao, Y; Sui, Y; Zhao, Y | 1 |
| Cai, F; Guo, L; Liu, X; Xu, P | 1 |
2 other study(ies) available for sesamin and Cancer of Prostate
| Article | Year |
|---|---|
Identification of a natural compound, sesamin, as a novel TRPM8 antagonist with inhibitory effects on prostate adenocarcinoma.
Topics: Adenocarcinoma; Cell Line, Tumor; Cell Proliferation; Dioxoles; HEK293 Cells; Humans; Lignans; Male; Molecular Docking Simulation; Molecular Structure; Prostatic Neoplasms; TRPM Cation Channels | 2020 |
Sesamin inhibits lipopolysaccharide-induced proliferation and invasion through the p38-MAPK and NF-κB signaling pathways in prostate cancer cells.
Topics: Cell Line, Tumor; Cell Proliferation; Cytokines; Dioxoles; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Lignans; Lipopolysaccharides; Male; Neoplasm Invasiveness; Neoplasm Proteins; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prostatic Neoplasms; Pyridines; Signal Transduction | 2015 |